Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lyvgen Biopharma Holdings Limited

Clinical trials sponsored by Lyvgen Biopharma Holdings Limited, explained in plain language.

Not yet finished but already full! 1 Completed 3

New hope for head and neck cancer patients who failed standard treatment

Disease control Ongoing

This study tests a new combination of drugs (LVGN6051, toripalimab, and paclitaxel) in 64 adults with advanced head and neck cancer that came back or spread after platinum-based treatment. The goal is to see if the combination is safe and shrinks tumors. Participants must be 18 o…

Phase: PHASE2 • Sponsor: Lyvgen Biopharma Holdings Limited • Aim: Disease control

Last updated May 26, 2026 07:25 UTC